What is Acobiom?
Acobiom is a biotechnology firm dedicated to advancing precision medicine through innovative biomarker discovery and diagnostic development. The company leverages its expertise in molecular biology, bioinformatics, and biostatistics to offer personalized medical care solutions. Its flagship product, GemciTest, is a non-invasive blood-based diagnostic test designed to predict patient responses to Gemcitabine therapy for pancreatic cancer, aiming to optimize treatment strategies and improve patient outcomes.
How much funding has Acobiom raised?
Acobiom has raised a total of $1.3M across 1 funding round:
Unspecified
$1.3M
Unspecified (2013): $1.3M with participation from Bpifrance
Key Investors in Acobiom
Bpifrance
Bpifrance is a French public investment bank that supports businesses in their growth and innovation phases, often focusing on strategic sectors like biotechnology and healthcare.
What's next for Acobiom?
The recent major strategic investment positions Acobiom for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, potentially expanding the company's diagnostic portfolio and enhancing its commercialization efforts. Acobiom's focus on personalized medicine and its proprietary diagnostic technologies suggest a trajectory towards becoming a key player in the oncology diagnostics landscape, offering tailored therapeutic insights to clinicians and patients.
See full Acobiom company page
